Search Results - "Paola Perini"
-
1
Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities
Published in Frontiers in neurology (17-05-2021)“…Treatment of pediatric-onset multiple sclerosis (POMS) has been tailored after observational studies and data obtained from clinical trials in adult-onset…”
Get full text
Journal Article -
2
A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis
Published in Annals of neurology (01-03-2010)“…Objective We assessed the occurrence, extent, and frequency of formation of cortical lesions (CLs) in patients with relapsing‐remitting (RR) and secondary…”
Get full text
Journal Article -
3
The changing clinical course of multiple sclerosis: A matter of gray matter
Published in Annals of neurology (01-07-2013)“…Objective Clinical and neuroimaging parameters predictive of the changing clinical course of multiple sclerosis (MS) from relapsing–remitting to secondary…”
Get full text
Journal Article -
4
Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis
Published in PloS one (29-08-2017)“…Increasing evidence suggest that neuronal damage is an early and diffuse feature of Multiple Sclerosis (MS) pathology. Analysis of the optic pathway may help…”
Get full text
Journal Article -
5
Hyper-reflective foci changes in RRMS under natalizumab therapy
Published in Frontiers in immunology (15-07-2024)“…Microglia (MG) is suggested to play an immunopathological role of in Multiple Sclerosis (MS). Since hyper-reflective foci (HRF) might mark MG activation,…”
Get full text
Journal Article -
6
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study
Published in Radiology (01-12-2011)“…To evaluate whether diffusion-tensor imaging can be combined with double inversion recovery to improve the detection of structural changes occurring in the…”
Get full text
Journal Article -
7
A comparison of natalizumab’s effects on SDMT between pediatric-onset and adult-onset multiple sclerosis patients
Published in Frontiers in neurology (06-11-2024)“…Pediatric-onset multiple sclerosis (POMS) patients often exhibit a wide range of cognitive deficits. Therefore, therapeutic approaches should aim not only to…”
Get full text
Journal Article -
8
D-KEFS ST Failure Identifies Multiple Sclerosis Patients With Worse Objective and Self-Perceived Physical and Cognitive Disability
Published in Frontiers in psychology (24-01-2019)“…The Brief Repeatable Battery of Neuropsychological Test (BRB-NT) does not explore the executive functions. We combined BRB-NT and Delis-Kaplan Executive…”
Get full text
Journal Article -
9
Slowly Progressive Optic Perineuritis as the First Clinical Manifestation of Sarcoidosis
Published in Journal of neuro-ophthalmology (01-03-2021)Get full text
Journal Article -
10
Cortical atrophy is relevant in multiple sclerosis at clinical onset
Published in Journal of neurology (01-09-2007)“…Increasing evidence suggests relevant cortical gray matter pathology in patients with Multiple Sclerosis (MS), but how early this pathology begins; its impact…”
Get full text
Journal Article -
11
Wide Cytokine Analysis in Cerebrospinal Fluid at Diagnosis Identified CCL-3 as a Possible Prognostic Factor for Multiple Sclerosis
Published in Frontiers in immunology (05-03-2020)“…Apart from IgG oligoclonal bands, no other biomarker has, to date, been validated for diagnostic and/or prognostic purposes in multiple sclerosis (MS). To…”
Get full text
Journal Article -
12
Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration
Published in Behavioral sciences (25-08-2023)“…(i) Background: Cognitive impairment in people with multiple sclerosis (MS) has been studied in relation to certain clinical variables (e.g., motor disability…”
Get full text
Journal Article -
13
Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis
Published in Therapeutic advances in neurological disorders (01-01-2023)“…Background: Paediatric-onset multiple sclerosis (POMS) therapeutic approach derives from of adult-onset multiple sclerosis (AOMS) tailored algorithms…”
Get full text
Journal Article -
14
Designing a Self-Perception Cognitive Questionnaire for Italian Multiple Sclerosis Patients (Sclerosi Multipla Autovalutazione Cognitiva, SMAC). A Preliminary Exploratory Pilot Study
Published in Frontiers in neurology (28-06-2021)“…Background: Although cognition in multiple sclerosis (MS) is assessed by means of several neuropsychological tests, only a few tools exist to investigate…”
Get full text
Journal Article -
15
Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project
Published in Neurology and therapy (01-10-2024)“…Introduction Multiple sclerosis (MS) is a chronic neurodegenerative disease that leads to impaired cognitive function and accumulation of disability, with…”
Get full text
Journal Article -
16
Decreased platelet number in multiple sclerosis during alemtuzumab infusion: a common, transient and clinically silent phenomenon
Published in Therapeutic advances in neurological disorders (01-01-2018)“…Background The cause and clinical significance of the transient decrease in platelet (PLT) count observed in relapsing remitting multiple sclerosis (RRMS)…”
Get full text
Journal Article -
17
Sexual Dysfunction in Multiple Sclerosis: The Role of Executive Function
Published in Behavioral sciences (29-04-2023)“…Cognitive impairment and sexual dysfunction are common symptoms in persons with Multiple Sclerosis (MS). The present study focuses on the relationship between…”
Get full text
Journal Article -
18
Characterization of SURF-1 Expression and Surf-1p Function in Normal and Disease Conditions
Published in Human molecular genetics (01-12-1999)“…Loss-of-function mutations of the SURF-1 gene have been associated with Leigh syndrome with cytochrome c oxidase (COX) deficiency. Mature Surf-1 protein…”
Get full text
Journal Article -
19
Cyclophosphamide-based combination therapies for autoimmunity
Published in Neurological sciences (01-09-2008)“…Immunomodulatory agent (IMA)-unresponsive multiple sclerosis (MS) can quickly evolve to a dramatic and irreversible disability. Treating these patients with…”
Get full text
Journal Article -
20
Disease-Modifying Drugs Reduce Cortical Lesion Accumulation and Atrophy Progression in Relapsing-Remitting Multiple Sclerosis: Results from a 48-Month Extension Study
Published in Multiple Sclerosis International (01-01-2015)“…Cortical lesions (CLs) and atrophy are pivotal in multiple sclerosis (MS) pathology. This study determined the effect of disease modifying drugs (DMDs) on CL…”
Get full text
Journal Article